Reduction to Preventive Doses of Enoxaparin After 3 to 6 Months of Treatment With Blood Thinners for Cancer-associated Blood Clots
Clinical trial NCT02752607 · TERMINATED
Trial details
- NCT number
- NCT02752607
- Sponsor
- Dr. Vicky Tagalakis
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2016-05-01
- Primary completion
- 2018-11-09
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.